Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
RedPath Integrated Pathology logo — company profile

RedPath Integrated Pathology

Founded 2004 22 employees Debt Financing Total: $9.40M Biotechnology, Health Care

General Information

Company Name RedPath Integrated Pathology
Founded Year 2004
Employees 22
Industries Biotechnology, Health Care
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with RedPath Integrated Pathology. To contact RedPath Integrated Pathology, visit redpathip.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does RedPath Integrated Pathology compare?

A PDF of RedPath Integrated Pathology and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting RedPath Integrated Pathology soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About RedPath Integrated Pathology

RedPath Integrated Pathology is a Pittsburgh-based molecular diagnostics laboratory specializing in innovative solutions for clinicians. The company's patented PathFinderTG® platform generates mutational profiles to assist physicians in resolving complex diagnostic challenges for patients at risk of cancer. RedPath conducts all clinical testing and research and development in its state-of-the-art, CLIA-certified and CAP-accredited laboratory. With over 20 years of scientific and clinical research backing its platform, RedPath has had studies published in over 200 peer-reviewed journals, including the New England Journal of Medicine. Recent healthcare economic studies have shown that the use of PathFinderTG significantly reduces healthcare costs. As a result of the robust clinical data supporting its platform, RedPath has received positive coverage decisions from Medicare and several private payers. Founded in 2004, RedPath is dedicated to providing state-of-the-art molecular diagnostic services to support gastroenterologists, pathologists, and other physicians in enhancing the clinical management of patients. The company's last investment was a $612.50K Debt Financing secured on April 9, 2013.

Business keywords: molecular diagnostics, PathFinderTG platform, cancer diagnostics, clinical testing, R&D, scientific research, healthcare economics, Medicare coverage, private payer coverage, oncology support services, reference laboratory, oncology testing platform, gastroenterology support, pathology support, Pittsburgh-based company

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $612.50K -
09 Apr 2013
Debt Financing $588.22K -
03 Aug 2012
Venture Round $1.60M 1
Plymouth Growth
Plymouth Growth
16 May 2011
Series A $6.50M 5
HealthCare Ventures CID Capital Inflexion Partners
HealthCare Ventures, CID Capital +3
20 Dec 2006
Pre Seed Round $100.00K 1
Pittsburgh Life Sciences Greenhouse
Pittsburgh Life Sciences Greenhouse
11 Aug 2006

RedPath Integrated Pathology Alternatives & Competitors

View All Alternatives
RedPath Integrated Pathology vs
Invivoscribe
Invivoscribe United States

Improving Lives with Precision Diagnostics®

199 employees
Biotechnology, Health Care
RedPath Integrated Pathology vs
CGC Genetics / CGC Centro Genetica Clinica
CGC Genetics / CGC Centro Genetica Clinica

For over two decades, CGC Genetics has been a leading provider of specialty genetic tests and has gr...

Private Equity
56 employees
Biotechnology, Health Care
RedPath Integrated Pathology vs
xMD Diagnostics, Inc.
xMD Diagnostics, Inc. United States

Enabling precision diagnostics

Non Equity Assistance
2 employees
Biotechnology, Health Care
View all alternatives

FAQ About RedPath Integrated Pathology

RedPath Integrated Pathology is a Pittsburgh-based molecular diagnostics laboratory focused on providing novel solutions for clinicians. Our patented PathFinderTG® platform produces mutational profiles to help physicians resolve complex diagnostic dilemmas in patients who are at risk of cancer. RedP...
RedPath Integrated Pathology was founded in 2004.
RedPath Integrated Pathology operates in Biotechnology and Health Care. Its work centres on molecular diagnostics, PathFinderTG platform, cancer diagnostics and clinical testing.
RedPath Integrated Pathology has approximately 22 employees.
RedPath Integrated Pathology has completed 5 funding rounds, raising a total of $9.40M. The latest funding stage is Debt Financing.
Top alternatives and competitors to RedPath Integrated Pathology include Invivoscribe, CGC Genetics / CGC Centro Genetica Clinica, xMD Diagnostics, Inc., HNL Lab Medicine, Dr Lal PathLabs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
RedPath Integrated Pathology and Invivoscribe are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for RedPath Integrated Pathology, https://bouncewatch.com/company/redpath-integrated-pathology, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes